Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > BUSINESS
BUSINESS
- Shinjiro Sato Tapped as Next President of Terumo
December 16, 2016
- Aspen Japan, Kissei Sign Copromotion Pact on Imuran
December 16, 2016
- Fujifilm to Acquire Takeda’s Reagent Unit for 155 Billion Yen
December 16, 2016
- Nippon Kayaku Introduces “MSLs” to Strengthen Detailing for Oncology Generics, Biosimilars, and Products in Development
December 16, 2016
- Interview: GSK’s New Evaluation System for Sales Reps Helps Deliver Science-Based Message
December 15, 2016
- FunPep, Shionogi Enter Joint Research Agreement for Vaccine Adjuvants
December 15, 2016
- Daiichi Sankyo Aims to File Antibody Drug Conjugate DS-8201 in 2020 for HER2-Positive Breast Cancer, Stomach Cancer
December 15, 2016
- Parkinson’s Med Nouriast Fails in PIII Study in US, Europe: Kyowa Kirin
December 14, 2016
- Daiichi Sankyo Links Arms with DarwinHealth on Cancer R&D
December 14, 2016
- Entyvio Delivers Higher Response Rates as 1st Line Biologic
December 13, 2016
- Astellas Europe to Transfer Rights for Pain Med Qutenza to Grünenthal
December 13, 2016
- Eisai’s BACE Inhibitor Cuts Beta Amyloid by 70% at 50 mg Daily
December 13, 2016
- Biogen Japan Seeks Japan Approval for Nusinersen
December 13, 2016
- Aspen Japan Starting on Right Foot on AG Biz: GSK Japan President
December 13, 2016
- Development of Novel Myeloid Leukemia Drug Gilteritinib Makes Progress: Astellas
December 12, 2016
- Mitsubishi Tanabe Wants to Make a Challenge in Experienced Field, President Says on Licensed Cell Therapy
December 9, 2016
- Nippon Kayaku Wins Reversal in Elplat Patent Suit
December 9, 2016
- Keytruda Launch Planned in Early Next Year: MSD Japan Chief
December 9, 2016
- Pfizer’s “Established” Pharma Business Expands to “Essential Health” to Include New Drugs, Copromoted Products
December 9, 2016
- Ethical Drug Sales Tumble 12.2% in October: Crecon Report
December 8, 2016
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…